Suchergebnisse - "Nicolini, Laura Ambra"

PubPharm (54)

31

Efficacy of lamivudine prophylaxis in preventing hepatitis B virus reactivation in patients with resolved infection undergoing allogeneic SCT and receiving rituximab

enthalten in: Infection | 2018

von Zappulo, E. | Nicolini, L. | Di Grazia, C. | +8

32

Efficacy of lamivudine prophylaxis in preventing hepatitis B virus reactivation in patients with resolved infection undergoing allogeneic SCT and receiving rituximab

enthalten in: Infection | 2018

von Zappulo, E. | Nicolini, L. | Di Grazia, C. | +8

33

Efficacy of lamivudine prophylaxis in preventing hepatitis B virus reactivation in patients with resolved infection undergoing allogeneic SCT and receiving rituximab

enthalten in: Infection | 2018

von Zappulo, E. | Nicolini, L. | Di Grazia, C. | +8

34

CD8+CD28-CD127loCD39+ regulatory T-cell expansion : A new possible pathogenic mechanism for HIV infection?

enthalten in: The Journal of allergy and clinical immunology | 2018

von Fenoglio, D. | Dentone, C. | Signori, A. | +22

35

Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures : What are the chances for second-line regimens?

enthalten in: Journal of hepatology | 2018

von Di Maio, V. | Cento, V. | Aragri, M. | +79

36

Management of chronic viral hepatitis in the hematological patient

enthalten in: Expert review of anti-infective therapy | 2018

von Nicolini, L. | Zappulo, E. | Viscoli, C. | +1

37

Successful recovery of associated interstitial nephritis and focal segmental glomerulosclerosis in patients with HCV and HIV treated with sofosbuvir and daclatasvir and revision of literature

enthalten in: Clinical nephrology. Case studies | 2018

von Mirabella, M. | Taramasso, L. | Nicolini, L. | +3

38

Implementing TB control in a rural, resource-limited setting : the stop-TB Italia project in Senegal

enthalten in: Multidisciplinary respiratory medicine | 2018

von Diaw, M. | Ndiaye, M. | Riccardi, N. | +8

39

Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patients

enthalten in: PloS one | 2018

von Taramasso, L. | Di Biagio, A. | Bovis, F. | +30

40

Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy

enthalten in: Infection | 2017

von Giacobbe, D. | Del Bono, V. | Mikulska, M. | +27

ErratumIn: Infection. 2017 Dec;45(6):929. - PMID 28983883